Perigon Wealth Management’s Eli Lilly LLY Stock Holding History

Perigon Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.8M	Buy	37,781 +835	+2%	+$847K	0.63%	30
2025 Q4	$39.7M	Sell	36,946 -473	-1%	-$452K	0.71%	26
2025 Q3	$28.6M	Buy	37,419 +1,028	+3%	+$765K	0.58%	30
2025 Q2	$28.4M	Sell	36,391 -157	-0.4%	-$122K	0.66%	26
2025 Q1	$30.2M	Sell	36,548 -420	-1%	-$349K	0.77%	20
2024 Q4	$28M	Sell	36,968 -1,580	-4%	-$1.31M	0.69%	24
2024 Q3	$34.2M	Sell	38,548 -674	-2%	-$606K	0.9%	18
2024 Q2	$35.5M	Buy	39,222 +256	+0.7%	+$205K	1.03%	14
2024 Q1	$30.3M	Sell	38,966 -2,028	-5%	-$1.44M	0.92%	17
2023 Q4	$23.9M	Buy	40,994 +1,614	+4%	+$942K	0.78%	20
2023 Q3	$21.2M	Buy	39,380 +365	+0.9%	+$188K	0.86%	19
2023 Q2	$18.3M	Buy	39,015 +25,875	+197%	+$10.9M	0.72%	28
2023 Q1	$4.51M	Buy	13,140 +1,001	+8%	+$338K	0.26%	89
2022 Q4	$4.44M	Buy	12,139 +1,179	+11%	+$418K	0.28%	90
2022 Q3	$3.54M	Sell	10,960 -20	-0.2%	-$6.34K	0.31%	71
2022 Q2	$3.56M	Buy	10,980 +1,826	+20%	+$548K	0.3%	75
2022 Q1	$2.62M	Buy	9,154 +583	+7%	+$150K	0.19%	105
2021 Q4	$2.37M	Buy	8,571 +876	+11%	+$222K	0.17%	112
2021 Q3	$1.78M	Sell	7,695 -283	-4%	-$69.8K	0.15%	124
2021 Q2	$1.83M	Sell	7,978 -264	-3%	-$53K	0.16%	122
2021 Q1	$1.54M	Buy	8,242 +816	+11%	+$160K	0.16%	125
2020 Q4	$1.25M	Buy	7,426 +394	+6%	+$58.8K	0.15%	115
2020 Q3	$1.04M	Buy	7,032 +1,371	+24%	+$212K	0.15%	123
2020 Q2	$929K	Buy	5,661 +926	+20%	+$142K	0.15%	112
2020 Q1	$690K	Buy	4,735 +2,099	+80%	+$288K	0.13%	131
2019 Q4	$349K	Buy	2,636 +178	+7%	+$20.6K	0.07%	177
2019 Q3	$270K	Sell	2,458 -604	-20%	-$67.2K	0.06%	184
2019 Q2	$339K	Sell	3,062 -3,025	-50%	-$356K	0.08%	159
2019 Q1	$720K	Sell	6,087 -665	-10%	-$80.9K	0.17%	98
2018 Q4	$776K	Buy	6,752 +4,665	+224%	+$521K	0.2%	88
2018 Q3	$224K	Buy	+2,087	New	+$209K	0.06%	223
2018 Q2	–	Sell	-2,287	Closed	-$177K	–	455
2018 Q1	$177K	Sell	2,287 -75	-3%	-$6.04K	0.07%	174
2017 Q4	$199K	Sell	2,362 -4	-0.2%	-$340	0.07%	145
2017 Q3	$202K	Sell	2,366 -30,917	-93%	-$2.54M	0.07%	199
2017 Q2	$2.74M	Sell	33,283 -33	-0.1%	-$2.69K	0.6%	47
2017 Q1	$2.8M	Sell	33,316 -240	-0.7%	-$19.2K	0.59%	49
2016 Q4	$2.83M	Sell	33,556 -74,734	-69%	-$5.57M	0.62%	46
2016 Q3	$8.69M	Sell	108,290 -41	-0%	-$3.28K	2.23%	4
2016 Q2	$8.53M	Sell	108,331 -5,838	-5%	-$440K	2.27%	4
2016 Q1	$7.81M	Hold	114,169	–	–	2.44%	6
2015 Q4	$9.62M	Sell	114,169 -6,628	-5%	-$550K	2.66%	6
2015 Q3	$10.1M	Sell	120,797 -6,099	-5%	-$515K	3%	5
2015 Q2	$10.6M	Buy	126,896 +2	+0%	+$152	2.79%	5
2015 Q1	$9.22M	Sell	126,894 -632	-0.5%	-$45K	2.53%	5
2014 Q4	$8.8M	Sell	127,526 -547	-0.4%	-$36.9K	2.64%	5
2014 Q3	$8.31M	Buy	128,073 +691	+0.5%	+$43.7K	2.47%	5
2014 Q2	$7.92M	Buy	+127,382	New	+$7.6M	2.26%	5

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Perigon Wealth Management's LLY Position: Q1 2026 in Review

Perigon Wealth Management increased its Eli Lilly (LLY) stake by 2.3% in Q1 2026, buying an estimated $847K and bringing the position to 37,781 shares worth $34.8M. The position accounts for 0.63% of the portfolio, ranked #30.

Perigon Wealth Management first reported a position in LLY in Q2 2014 and has held it in 47 quarters since. The position peaked at $39.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Perigon Wealth Management held 37,781 shares of Eli Lilly worth $34.8M as of Q1 2026.
Perigon Wealth Management bought 835 Eli Lilly shares in Q1 2026, an estimated $847K.
Eli Lilly made up 0.63% of Perigon Wealth Management's portfolio in Q1 2026, its #30 holding.
Perigon Wealth Management first reported a position in Eli Lilly in Q2 2014 and has held it in 47 quarters since.
Perigon Wealth Management's Eli Lilly position peaked at $39.7M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.